Tel: 01202 443064

11 Shelley Road, Bournemouth, Dorset, BH1 4JQ

Exhibitors & Sponsors

The following companies have given funding towards the cost of the charity’s two day conference in 2016 but have no input into the agenda or content. Staff from these companies will be present at the event and may have a stand promoting their products.

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realise the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.

Lilly UK

Lilly UK Limited is one of the world’s largest research-based pharmaceutical companies, dedicated to creating and delivering innovative pharmaceutical healthcare solutions that enable people to live longer, healthier and more active lives. Our research and development efforts constantly strive to address the world’s growing unmet medical needs in several different clinical areas, which include many aspects of metabolic bone disease.

 

Internis Pharmaceuticals Ltd

Internis is a pharmaceutical company engaged in the development and commercialisation of highly effective and innovative new medicines aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency. Internis is a pharmaceutical company engaged in the development and commercialisation of highly effective and innovative new medicines aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency.

 

Consilient Health

Consilient Health is a young & dynamic, rapidly growing pharmaceutical company with a portfolio of generic and speciality pharmaceutical products. We have a skilled and very experienced management team who can add value to our partners in the UK market and elsewhere in Europe. We are independent & financially strong.

 

UCB is a Global biopharmaceutical company focused on discovering and developing innovative medicines and forming working partnerships with the scientific and medical community to create solutions to transform the lives of patients in the UK. UCB has built a strong presence across neurology and immunology with several in-licence products and a strong pipeline. Today, we are building our pipeline in our existing therapy areas of focus and expanding our research into the area of bone health where we hope to bring novel therapies to reduce the burden of the half a million fragility fractures caused by osteoporosis in the UK every year.